
What the Therapeutic Products Bill Means for Supplements?
Look, the whole healthcare world is moving, perpetually. And with that movement, the legal frameworks governing how we, as manufacturers, actually make and then get to market these therapeutic products are changing. The biggest change, the one you absolutely cannot ignore, is the Therapeutic Products Bill (TPB). It reconstructs, fundamentally, how every single natural health […]

Behind the Scenes of Therapeutic Biologics: QC and Safety
If you’ve ever wondered why some medicines feel almost magical in how targeted they are, chances are we’re talking about therapeutic biologics – complex drugs derived from living cells. From monoclonal antibodies to recombinant proteins, they tackle diseases in ways traditional drugs often can’t. But here’s the thing: these aren’t simple pills you can mass-produce […]

Therapeutic Biologicals: Navigating Challenges and Opportunities
Therapeutic biologicals – including monoclonal antibodies, recombinant proteins, biosimilars, and cell/gene therapies—represent the future of targeted healthcare. As the global pharmaceutical landscape shifts, India is well-positioned to play a pivotal role. But realizing this potential requires addressing key hurdles while leveraging strategic advantages. Manufacturing Complexity & Quality Assurance: Biological products are inherently complex, derived from […]